Navigation Links
American Association for Cancer Research (AACR) Deploys Collexis' Reviewer Finder and Journal Dashboard Applications
Date:2/18/2009

Reviewer Finder to Speed up the Peer Review Process!

COLUMBIA, S.C., Feb. 18 /PRNewswire-FirstCall/ -- Collexis Holdings Inc. (OTC Bulletin Board: CLXS), a leading developer of semantic search and knowledge discovery software, announced today that the American Association for Cancer Research (AACR) has licensed the Collexis' Reviewer Finder and Journal Dashboard applications for the 6 AACR cancer research journals.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090107/CLW051LOGO )

"The Collexis Review Finder application will certainly enhance and improve our peer review process as we continuously strive to target the most appropriate reviewers", stated Diane Scott-Lichter, Publisher of AACR. "The Journal Dashboard will provide us with key insights concerning the positioning of our journals in the area of cancer research."

"Having the AACR to sign up for our Reviewer Finder application is quite gratifying for us since AACR is the first society to adopt the Reviewer Finder for the publishing process - until today most of the Reviewer Finder customers were other funding organizations like the NHLBI at the NIH and the Wellcome Trust," said Christian Herzog, MD, Managing Director of the Collexis STM Business Unit. "As the AACR begins to use the Journal Dashboards as journal portfolio analysis tools, we are very confident that it will help them to sharpen the profile of their journals."

The Collexis Reviewer Finder helps publishing organizations in two very important ways: first it assists in reducing the time to identify the most qualified reviewers from hours to virtually minutes by automatically suggesting best matching reviewers for a manuscript, secondly it enhances security by identifying potential conflicts of reviewers based on co-authorship and institutional affiliation. The Collexis Review
'/>"/>

SOURCE Collexis Holdings Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. American Institute for Medical and Biological Engineering Appoints Dr. Gualberto Ruano to College of Fellows
2. BioIQ Supports American Heart Month to Raise Awareness About Heart Disease, the #1 Killer of Women
3. New General Manager, Transition to New Raleigh Offices Highlight Datatrials Expansion of North American Operations
4. ERYtech Pharma Signs an Agreement With the Penn Jersey Region of American Red Cross
5. American Oriental Bioengineering to Participate in the 2009 UBS Greater China Conference
6. American Oriental Bioengineering Comments on Recent Property Purchase
7. Tips from the journals of the American Society for Microbiology
8. Elsevier Introduces The American Journal of Medicine Blog
9. The American Ceramic Society releases new ACerS-NIST phase equilibria diagrams CD-ROM database
10. Transgenomic Receives Accreditation From College of American Pathologists
11. Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...ewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, IN...an update on its European commercial launch of MuG... a debilitating side effect of radiation treatment... by Access, partner, SpePharm, in six European cou...Greece and Sweden. Access is conducting pre-market...
(Date:12/3/2009)...3 Peregrine Pharmaceutic... will release its financial results for the second...at 7:00 a.m. EST and will host a conference call a...T on the same day. ,, Peregrine,s senior manage... quarter ended October 31, 2009 and will review re...
(Date:12/3/2009)...dia, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, ...ke Biotechnology Co. Ltd.,( http://www.beikebiotec...tic,Foot Care in New Delhi, India, November 22, 20...d regenerative medicine company. , The co...tion (IPA), aimed,to help podiatrists and research...
(Date:12/2/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, Neurostimulation - A Global Market Pe...4232/Neurostimulation---A-Global-Market-Perspectiv...tands enthused by the growing base of aging popula...es such as, Parkinson,s, and Alzheimer,s disease. ...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6
...Probe,s Commercial Expansion in, Fast-Growing Euro...ies and Markers -, ...t Standalone Molecular, Diagnostics Company, Provi... Diverse Customer Needs Around the Worl...asdaq: GPRO ), a pioneer and leader in nucleic ac...
...fted to maneuver separately without any obvious gu...ctures after years of continuing research led by a...elous to be able to do assembly and control at thi...gs," said Bruce Donald, a Duke professor of comput... shaped something like a spatula but with dimensio...
..., June 3, 2008, TIME: 9:30 a.m. Eastern Tim...EO Kendle (Nasdaq: KNDL ) will conduct a telepho...sday, June 3 at 9:30 a.m. Eastern Time to,discuss ...Corporation that,was announced on May 30 and to pr...tion and answer session will follow., (Logo: htt...
Other Biology Technology:Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 2Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 3Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 4Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 5Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 6Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics 7Microrobots dance on something smaller than a pin's head 2Microrobots dance on something smaller than a pin's head 3Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress 2
(Date:12/2/2009)... identification of substances involved in the Jeky...arine bacteria into killers that cause "coral blea... Science & Technology , a semi-monthly journal. ,...lready has destroyed up to 30 percent of the world...ays to slow or stop the damage. One known culprit ...
(Date:12/2/2009)...alif. and PALM HARBOR, Fla., Dec. 2 /PRNewswire-Fi... ("CIC") (OTC Bulletin Board: CICI), a leading sup...ss process automation in the financial industry* a...verification and Docubase Systems Inc. ("Docubase"...agement (EDM) software provider announced today th...
(Date:12/2/2009)...f carbon about a nanometer in diameterhave been hi...rastrong fibers, electrical wires in molecular dev...s. Thanks to a new development by researchers at t...(NIST) and five partners, you can add one more app... an aggressive form of breast cancer. , HER2 is ...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Red Cross Leader Describes First Year Triumphs Challenges 52332 1Red Cross Leader Describes First Year Triumphs Challenges 52332 2Amylin Pharmaceuticals Reports Second Quarter Financial Results 52326 1Amylin Pharmaceuticals Reports Second Quarter Financial Results 52326 2Amylin Pharmaceuticals Reports Second Quarter Financial Results 52326 3Amylin Pharmaceuticals Reports Second Quarter Financial Results 52326 4Amylin Pharmaceuticals Reports Second Quarter Financial Results 52326 5Amylin Pharmaceuticals Reports Second Quarter Financial Results 52326 6Amylin Pharmaceuticals Reports Second Quarter Financial Results 52326 7Amylin Pharmaceuticals Reports Second Quarter Financial Results 52326 8Amylin Pharmaceuticals Reports Second Quarter Financial Results 52326 9Amylin Pharmaceuticals Reports Second Quarter Financial Results 52326 10Amylin Pharmaceuticals Reports Second Quarter Financial Results 52326 11Amylin Pharmaceuticals Reports Second Quarter Financial Results 52326 12University HealthSystem Consortium Recognized as a Company That Cares for Sixth Year in a Row 52321 1University HealthSystem Consortium Recognized as a Company That Cares for Sixth Year in a Row 52321 2
...dy, led by Grace Gill, PhD, Tufts University Schoo...n called SUMO (Small Ubiquitin-related Modifier) g...of chromatin to regulate expression of genes. Chro...make up chromosomes. The interaction between SUMO ... of cancer and neurodegenerative diseases such as ...
...something of an enigma that our brain can achieve ...ch lies at the interface between vision and langua...ought to have been invented only around four to fi...has elapsed to allow the evolution of specialized ... techniques have made some progress in understandi...
...ral Physiology features an article and accompanyi...vances previous conclusions about the essential fe...otassium (Kv) channel. , As Richard Horn (Departm...ute of Hyperexcitability, Jefferson Medical Colleg...he essential features of the voltage-sensing mecha...
Other Biology News:SUMO protein guides chromatin remodeler to suppress genes 2Early brain activity sheds new light on the neural basis of reading 2Early brain activity sheds new light on the neural basis of reading 3
Scaffold Software from Proteome Software Inc.
Normal Goat Serum from Calbiochem
TRIzol LS Reagent from Invitrogen
UltraPure DNase/RNase-Free Distilled Water from Invitrogen
Biology Products: